GRECO, ELIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.262
EU - Europa 1.149
AS - Asia 888
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 3
SA - Sud America 2
Totale 10.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.249
CN - Cina 714
FI - Finlandia 317
SE - Svezia 203
IT - Italia 202
DE - Germania 156
UA - Ucraina 148
VN - Vietnam 95
GB - Regno Unito 55
KR - Corea 23
IN - India 21
EU - Europa 15
RU - Federazione Russa 14
IE - Irlanda 13
NL - Olanda 13
CA - Canada 11
FR - Francia 11
IR - Iran 8
JP - Giappone 8
RO - Romania 6
SI - Slovenia 6
TR - Turchia 4
HK - Hong Kong 3
IQ - Iraq 3
SG - Singapore 3
ES - Italia 2
GR - Grecia 2
ID - Indonesia 2
MX - Messico 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 10.319
Salva come PNG Salva come JPEG
Città #
Ann Arbor 937
Woodbridge 891
Chandler 863
Houston 754
Fairfield 743
Jacksonville 711
Ashburn 531
Wilmington 422
Cambridge 329
Seattle 265
Princeton 230
Des Moines 187
Medford 173
Beijing 169
Nanjing 148
Helsinki 118
Roxbury 102
Dong Ket 94
Boardman 91
San Diego 68
Guangzhou 49
Nanchang 48
Shenyang 36
New York 35
Hebei 33
Jiaxing 32
Changsha 28
Padova 27
Tianjin 25
Jinan 22
Gangdong-gu 19
Norwalk 16
Shanghai 15
Zhengzhou 15
London 13
Redwood City 13
Dublin 12
Rome 11
Bologna 10
Falls Church 10
Washington 10
Haikou 9
Taizhou 9
Lanzhou 8
Naples 8
Pune 8
Borås 7
Kharkiv 7
Kunming 7
Cagliari 6
Indiana 6
Milan 6
Munich 6
Rockville 6
Tappahannock 6
Turin 6
Florence 5
Fuzhou 5
Hefei 5
Montreal 5
Ningbo 5
Ogden 5
Hangzhou 4
Lappeenranta 4
Poggiomarino 4
Redmond 4
Vicenza 4
Amsterdam 3
Augusta 3
Bucharest 3
Detroit 3
Genoa 3
Kilburn 3
Malo 3
Mestre 3
Nürnberg 3
Okazaki 3
Yenibosna 3
Atlanta 2
Bari 2
Bassano del Grappa 2
Brescia 2
Campobasso 2
Chengdu 2
Chicago 2
Geislingen an der Steige 2
Guadalajara 2
Hamburg 2
Hong Kong 2
Legnago 2
Los Angeles 2
Malang 2
Pontecorvo 2
Prata di Pordenone 2
Samos 2
San Francisco 2
Seongnam-si 2
Simi Valley 2
Taiyuan 2
Udine 2
Totale 8.537
Salva come PNG Salva come JPEG
Nome #
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 172
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 138
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 136
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 124
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 121
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 120
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 120
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 113
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 108
Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. 105
Serum antibodies anti-H. pylori and anti CagA: a comparison between four different assays. 103
La mutazione S59P del gene TNFRSF1A, associata alla TRAPS, causa l'attivazione costitutiva della via del segnale NFkB 103
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 101
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 100
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 100
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 98
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 98
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 97
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 94
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 94
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 93
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 92
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 92
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 91
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 91
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 90
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 87
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 82
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 82
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 81
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 81
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 80
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 79
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 78
Metastatic colo-rectal cancer cells stimulate collagen production by fibroblasts. 78
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 77
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 77
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 76
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 73
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 72
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 71
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 70
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 70
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 69
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 69
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 69
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 69
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 67
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 67
NT-S100A8 effects on cell signalling. 66
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 66
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 65
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 65
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 64
Gastropanel: a useful screening test in paediatric populations 64
Predisposizione al cancro del pancreas: ruolo dei polimorfismi dei geni XRCC1, XRCC3 e CYP1A1 63
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 63
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 63
Carcinogenetic potential of the WSR cagA region. 63
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 62
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 62
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 62
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 62
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 61
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 61
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 60
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 60
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 60
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 59
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 59
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 59
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 59
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 58
A new indirect chemiluminescent immunoassay to measure anti-transglutaminase antibodies: more than a promise 58
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 58
Gene therapy with HSV-TK: a promising tool for pancreatic cancer treatment? 57
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 56
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 56
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 56
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 56
Engineering diphteria toxin in pancreatic cancer cells: a promising tool for therapy. 55
Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1 54
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 54
VKORC1 and CYP2C9 pharmacogenetics: relevance in warfarin maintenance dosing prediction. 53
Profilo di espressione di mioblasti condizionati da cellule di cancro del pancreas: analisi mediante microarray di 5000 geni muscolari 53
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 53
Isolation and characterization of pancreatic cancer (PC) diabetogenic factor: a 14 aminoacids peptide corresponding to the N-terminal sequence of an S-100 calcium binding protein 52
Identification of new IL12A and IL12B genes polymorphisms as host genetic factors interplaying with H. pylori 52
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 52
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 51
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 51
Analogues of vitamin E epitomized by alpha-tocopherol succinate (alpha-tos) for pancreatic cancer treatment: in vitro results induce caution for in vivo application. 51
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 50
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 50
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 50
Polimorfismi del gene TNFa : effetto sulla prognosi e l`esito del cancro del pancreas (CP)Polimorfismi del gene TNFa : effetto sulla prognosi e l`esito del cancro del pancreas (CP) 48
Pancreatic cancer gene therapy with diphteria toxin A (DTA) and its variants CRM176 and CRM197. 48
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 47
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 47
Standardization of K-ras point mutations detection in serum derived DNA: use of the restriction enzyme BstO I 46
Totale 7.418
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.287
article - articoli 9.606
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019512 0 0 0 0 0 0 0 0 0 110 190 212
2019/20201.774 348 36 40 106 144 132 103 194 151 281 146 93
2020/20211.277 63 108 54 161 65 100 14 116 171 89 172 164
2021/20221.462 19 353 77 50 49 108 33 92 72 14 153 442
2022/20231.939 379 211 25 206 339 302 9 110 232 19 71 36
2023/2024787 36 121 105 73 67 166 70 87 23 39 0 0
Totale 10.360